Patents

US 12559734 B2: Reverse transcriptase mutants with increased activity and thermostability

Granted
2026-02-24
Filed
2022-01-18 application 17578275
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure provides Moloney murine leukemia virus (MMLV) reverse transcriptase (RTase) mutants. The disclosure as provides suitable amino acid positions in MMLV RTase for mutagenesis and methods and kits for using MMLV RTase mutants to synthesize cDNA from RNA templates.

Source: PTBLXML, file of 2026-02-24 (ipgb20260224.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
INTEGRATED DNA TECHNOLOGIES, INC. 103 patentsUS company or organizationCoralville, IAINTEGRATED DNA TECHNOLOGIES, INC. State business registration EXACT high confidence: identical full name and statePTBLXML, file of 2026-02-24

Inventors

InventorPlacePatentsPerson pageSource
Sarah Franz BeaudoinIowa City, IA5PTBLXML, file of 2026-02-24
Christopher Anthony VakulskasNorth Liberty, IA22PTBLXML, file of 2026-02-24

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/12PTBLXML, file of 2026-02-24
C12YEnzymesC12Y207/07049PTBLXML, file of 2026-02-24

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.